AU2004322710B2 - Compositions and methods for the management of hyperproliferative dermatological conditions - Google Patents

Compositions and methods for the management of hyperproliferative dermatological conditions Download PDF

Info

Publication number
AU2004322710B2
AU2004322710B2 AU2004322710A AU2004322710A AU2004322710B2 AU 2004322710 B2 AU2004322710 B2 AU 2004322710B2 AU 2004322710 A AU2004322710 A AU 2004322710A AU 2004322710 A AU2004322710 A AU 2004322710A AU 2004322710 B2 AU2004322710 B2 AU 2004322710B2
Authority
AU
Australia
Prior art keywords
boswellic acid
beta
skin
scalp
nails
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2004322710A
Other languages
English (en)
Other versions
AU2004322710A1 (en
Inventor
Muhammed Majeed
Subbalakshmi Prakash
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sami Chemicals and Extracts Ltd
Original Assignee
Sami Chemicals and Extracts Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/710,778 external-priority patent/US7582314B2/en
Application filed by Sami Chemicals and Extracts Ltd filed Critical Sami Chemicals and Extracts Ltd
Publication of AU2004322710A1 publication Critical patent/AU2004322710A1/en
Assigned to SAMI LABS LTD. reassignment SAMI LABS LTD. Request for Assignment Assignors: MAJEED, MUHAMMED, PRAKASH, SUBBALAKSHMI
Application granted granted Critical
Publication of AU2004322710B2 publication Critical patent/AU2004322710B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
AU2004322710A 2004-08-02 2004-10-14 Compositions and methods for the management of hyperproliferative dermatological conditions Ceased AU2004322710B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/710,778 2004-08-02
US10/710,778 US7582314B2 (en) 2003-12-03 2004-08-02 Compositions and methods for the management of hyperproliferative dermatological conditions
PCT/US2004/033846 WO2006022762A1 (en) 2004-08-02 2004-10-14 Compositions and methods for the management of hyperproliferative dermatological conditions

Publications (2)

Publication Number Publication Date
AU2004322710A1 AU2004322710A1 (en) 2006-03-02
AU2004322710B2 true AU2004322710B2 (en) 2011-03-31

Family

ID=35967805

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004322710A Ceased AU2004322710B2 (en) 2004-08-02 2004-10-14 Compositions and methods for the management of hyperproliferative dermatological conditions

Country Status (12)

Country Link
EP (1) EP1791423B1 (https=)
JP (1) JP4820819B2 (https=)
CN (1) CN101132693B (https=)
AU (1) AU2004322710B2 (https=)
DK (1) DK1791423T3 (https=)
ES (1) ES2422893T3 (https=)
NZ (1) NZ552027A (https=)
PL (1) PL1791423T3 (https=)
PT (1) PT1791423E (https=)
RU (1) RU2366412C2 (https=)
WO (1) WO2006022762A1 (https=)
ZA (1) ZA200700694B (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101682512B1 (ko) * 2008-09-15 2016-12-05 라일라 뉴트라슈티칼스 보스웰리아 세라타 추출물을 포함하는 상승적인 항-염증 조성물
ITVR20080125A1 (it) * 2008-11-13 2010-05-14 Phytonature Sas Di Masini Dr Antoni O E C Nuova forma di preparazione ed utilizzo della boswellia serrata
RU2578025C2 (ru) * 2010-02-15 2016-03-20 Лайла Ньютрасьютикалз Новый низкополярный экстракт камеде-смолы boswellia и его синергетические композиции
US20110218172A1 (en) * 2010-03-02 2011-09-08 Muhammed Majeed Composition for down-regulating pro-inflammatory markers
CN102670690A (zh) * 2011-03-14 2012-09-19 苏州博创园生物医药科技有限公司 一种抗牛皮癣纯天然药物乳膏及其制备方法
CN102670565A (zh) * 2011-03-14 2012-09-19 苏州博创园生物医药科技有限公司 一种含天然药物的透皮吸收贴片
CN103193853A (zh) * 2012-01-06 2013-07-10 苏州博创园生物医药科技有限公司 用于治疗银屑病的化合物、组合物及其制备方法
US9498423B2 (en) * 2012-05-07 2016-11-22 Sami Labs Limited Synergistic selenopeptide formulations for the protection of dermal papilla cells
JP2019513775A (ja) * 2016-04-19 2019-05-30 アズーラ オフサルミックス エルティーディー． 角化症の処置のための組成物
US9975917B1 (en) 2017-09-20 2018-05-22 King Saud University Pentacyclic triterpenoidal derivatives
EP4087655A4 (en) 2020-01-10 2024-02-21 Azura Ophthalmics Ltd INSTRUCTIONS FOR COMPOSITION AND SENSITIVITY
EP4295842A1 (en) 2022-06-24 2023-12-27 Faaborg Pharma - IP ApS A skin care composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3670084A (en) * 1969-06-20 1972-06-13 Leopoldo F Montes Method of treating psoriasis with cycloheximide
DE4201903B4 (de) * 1992-01-24 2004-04-15 Hermann P.T. Prof. Dr.Med. Ammon Pharmazeutische Verwendung von Boswelliasäuren
DE4445728A1 (de) * 1994-12-21 1996-06-27 Simmet Th Prof Dr Verwendung von Boswelliasäure zur Behandlung von Hirntumoren
US5536506A (en) * 1995-02-24 1996-07-16 Sabinsa Corporation Use of piperine to increase the bioavailability of nutritional compounds
RU2152218C1 (ru) * 1998-04-21 2000-07-10 Дальневосточный государственный медицинский университет Способ лечения псориаза
CN1064264C (zh) * 1998-04-28 2001-04-11 山东省滨州卫生学校 富硒灵芝在制备治疗银屑病的药物中的应用
US6399105B1 (en) * 1999-01-20 2002-06-04 Peter Donald Collin Sea cucumber carotenoid lipid fraction products and methods of use
WO2000066111A1 (en) * 1999-04-30 2000-11-09 Sabinsa Corporation Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
CA2451267A1 (en) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
GB0230203D0 (en) * 2002-12-27 2003-02-05 Domantis Ltd Fc fusion
BR0317885A (pt) * 2002-12-30 2005-12-06 Celgene Corp Composto, isÈmeros s e r enantiomericamente puros do mesmo, composição farmacêutica e métodos de inibir pde4 e mmp, de modular a produção de tnf-alfa, de tratar ou prevenir mds, de tratar doença mieloproliferativa, angiogênese indesejada, câncer, uma doença, inflamação dos pulmões, depressão, distúrbio pulmonar obstrutivo crÈnico, doença inflamatória do intestino, dermatite atópica, psorìase, doença de crohn, artrite reumatóide, asma, eslcerose múltipla e doença cardìaca em um mamìfero e de tratar, prevenir ou controlar a sìndrome de dor regional complexa

Also Published As

Publication number Publication date
NZ552027A (en) 2009-10-30
EP1791423A1 (en) 2007-06-06
JP2008508354A (ja) 2008-03-21
JP4820819B2 (ja) 2011-11-24
RU2007102720A (ru) 2008-09-10
EP1791423A4 (en) 2009-06-17
ZA200700694B (en) 2007-11-28
WO2006022762A1 (en) 2006-03-02
AU2004322710A1 (en) 2006-03-02
PL1791423T3 (pl) 2013-09-30
ES2422893T3 (es) 2013-09-16
WO2006022762B1 (en) 2006-05-04
CN101132693B (zh) 2012-11-07
DK1791423T3 (da) 2013-08-05
CN101132693A (zh) 2008-02-27
PT1791423E (pt) 2013-08-02
EP1791423B1 (en) 2013-05-01
RU2366412C2 (ru) 2009-09-10

Similar Documents

Publication Publication Date Title
ZA200700694B (en) Compositions and methods for the management of hyperproliferative dermatological conditions
KR101699572B1 (ko) 주사 또는 홍안 관련 피부 질환의 치료를 위한, 베르베린 또는 그의 유사체를 함유하는 조성물
Raut et al. Management of psoriasis with nutraceuticals: An update
US7582314B2 (en) Compositions and methods for the management of hyperproliferative dermatological conditions
CA2408541C (en) Treating eczema and/or psoriasis
AU2001260833A1 (en) Treating eczema and/or psoriasis
GB2453157A (en) Compositions and their use for treating skin conditions
US8586064B2 (en) Treating eczema and/or psoriasis
US11590211B2 (en) Systems for treating dermal inflammatory conditions
Tope et al. Mechanisms of antiulcerogenic effect of garlic (Allium sativum) in albino rats
Nille et al. Effect of an Ayurveda treatment in palmoplantar psoriasis: A case study
BEHANDLUNG et al. DERMATOLOGICAL CONDITIONS
Nangana et al. Efficacy of AMXs, Natural Filaggrin and TNF-alpha Modulators containing V. amygdalina leaf Extracts, on Inflammatory Skin Diseases
CN100569245C (zh) 乳香在制备治疗痛风的药物中的用途
Vaidya et al. Application of Aloe Vera in Dentistry
Shamim et al. Olive oil: an effective emollient for lichen simplex chronicus
Doddamani et al. www. ijrap. net (ISSN: 2229–3566)
Yang et al. and Sjögren's Syndrome with Special Reference to Latest Studies
NZ522434A (en) Treating eczema and/or psoriasis
Shakya et al. www. ijrap. net (ISSN: 2229–3566)
HK1126957A1 (en) Krill extracts for prevention and/or treatment of cardiovascular diseases

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: SAMI LABS LTD.

Free format text: FORMER APPLICANT(S): MAJEED, MUHAMMED; PRAKASH, SUBBALAKSHMI

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired